A Vacheron

684 total citations
57 papers, 493 citations indexed

About

A Vacheron is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A Vacheron has authored 57 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 17 papers in Surgery and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A Vacheron's work include Cardiac Imaging and Diagnostics (10 papers), Cardiac Valve Diseases and Treatments (8 papers) and Coronary Interventions and Diagnostics (8 papers). A Vacheron is often cited by papers focused on Cardiac Imaging and Diagnostics (10 papers), Cardiac Valve Diseases and Treatments (8 papers) and Coronary Interventions and Diagnostics (8 papers). A Vacheron collaborates with scholars based in France, United States and Switzerland. A Vacheron's co-authors include Claude Le Feuvre, Gérard Helft, Eugène McFadden, Gilles Grollier, Jean‐Marc Lablanche, Michel E. Bertrand, C Dreux, Jean‐Pierre Michel, J Machecourt and Nicolas Danchin and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

A Vacheron

54 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Vacheron France 11 267 250 115 104 69 57 493
G Montalescot France 11 387 1.4× 194 0.8× 135 1.2× 64 0.6× 36 0.5× 28 567
D. Eccleston Australia 15 571 2.1× 400 1.6× 179 1.6× 101 1.0× 43 0.6× 60 788
S. Behar Israel 13 320 1.2× 94 0.4× 82 0.7× 79 0.8× 84 1.2× 31 506
Antônio Carlos Carvalho Brazil 14 395 1.5× 248 1.0× 152 1.3× 107 1.0× 89 1.3× 63 591
Efraín Gaxiola United States 12 330 1.2× 167 0.7× 115 1.0× 59 0.6× 19 0.3× 22 490
Imad A. Alhaddad Jordan 14 372 1.4× 148 0.6× 66 0.6× 105 1.0× 39 0.6× 49 536
H. W. Höpp Germany 12 221 0.8× 112 0.4× 54 0.5× 67 0.6× 54 0.8× 54 401
J. Le Dall France 4 267 1.0× 92 0.4× 67 0.6× 38 0.4× 33 0.5× 4 421
Mouin Abdallah United States 13 426 1.6× 324 1.3× 144 1.3× 62 0.6× 40 0.6× 29 610
Dzifa Wosornu United Kingdom 6 449 1.7× 91 0.4× 58 0.5× 61 0.6× 72 1.0× 10 595

Countries citing papers authored by A Vacheron

Since Specialization
Citations

This map shows the geographic impact of A Vacheron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Vacheron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Vacheron more than expected).

Fields of papers citing papers by A Vacheron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Vacheron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Vacheron. The network helps show where A Vacheron may publish in the future.

Co-authorship network of co-authors of A Vacheron

This figure shows the co-authorship network connecting the top 25 collaborators of A Vacheron. A scholar is included among the top collaborators of A Vacheron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Vacheron. A Vacheron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vacheron, A. (2018). Présentations d’ouvrages. Bulletin de l Académie Nationale de Médecine. 202(5-6). 1265–1267.
2.
Bouvenot, G, Jean–Paul Bounhoure, Jean‐Louis Montastruc, & A Vacheron. (2014). Rapport sur les anticoagulants oraux directs (AOD) (antérieurement appelés « nouveaux anticoagulants oraux » ou NACO). Bulletin de l Académie Nationale de Médecine. 198(6). 1157–1195. 1 indexed citations
3.
Vacheron, A. (2011). Complications cardiovasculaires du diabète. Bulletin de l Académie Nationale de Médecine. 195(1). 205–211. 1 indexed citations
4.
Vacheron, A, et al.. (2007). Recommandations de l’Académie nationale de médecine concernant la prise en charge extrahospitalière de l’arrêt cardiocirculatoire. Bulletin de l Académie Nationale de Médecine. 191(1). 149–154. 4 indexed citations
5.
Vacheron, A, et al.. (2007). Recommandations de l’Académie nationale de médecine pour la prise en charge des patients après infarctus du myocarde. Bulletin de l Académie Nationale de Médecine. 191(8). 1763–1777. 2 indexed citations
6.
Vacheron, A. (2004). Recommandations concernant les traitements anticoagulants par les antivitamines K. Bulletin de l Académie Nationale de Médecine. 188(5). 867–868. 2 indexed citations
7.
Feuvre, Claude Le, et al.. (2001). La dissection aortique chez les Noirs. À propos de six cas congolais. Annales de Cardiologie et d Angéiologie. 50(3). 133–141. 4 indexed citations
9.
Helft, Gérard, Paolo Bartolomeo, Azfar Zaman, et al.. (1999). The Heparin Management Test. Thrombosis Research. 96(6). 481–485. 6 indexed citations
10.
Feuvre, Claude Le, Patrizia Paterlini-Bréchot, Luc Maillard, et al.. (1998). Arterial response to mild balloon injury in the normal rabbit. Coronary Artery Disease. 9(12). 805–814. 6 indexed citations
11.
Helft, Gérard, Claude Le Feuvre, Ismaı̈l Elalamy, et al.. (1998). Comparison of activated clotting times to heparin management test for adequacy of heparin anticoagulation in percutaneous transluminal coronary angioplasty. Catheterization and Cardiovascular Diagnosis. 45(3). 329–331. 5 indexed citations
12.
Bertrand, Michel E., Eugène McFadden, Jean‐Charles Fruchart, et al.. (1997). Effect of Pravastatin on Angiographic Restenosis After Coronary Balloon Angioplasty fn1fn1This study was supported by a grant from Bristol Myers Squibb Laboratories, Paris.. Journal of the American College of Cardiology. 30(4). 863–869. 109 indexed citations
13.
Vacheron, A, et al.. (1996). Talking Effect and White Coat Phenomenon in Hypertensive Patients. Behavioral Medicine. 22(3). 114–122. 10 indexed citations
14.
Mounier‐Véhier, Claire, Arlette Girard, Silla M. Consoli, et al.. (1995). Cardiovascular reactivity to a new mental stress test: The maze test. Clinical Autonomic Research. 5(3). 145–150. 8 indexed citations
15.
Tabone, X, et al.. (1994). Coronary angioplasty in patients 75 years and older; comparison with coronary bypass surgery. European Heart Journal. 15(2). 213–217. 13 indexed citations
16.
Tabone, X, et al.. (1993). Percutaneous Coronary Angioplasty in Patients Over 75 Years Old: Immediate and Mid‐term Results. Journal of Interventional Cardiology. 6(2). 169–174. 1 indexed citations
17.
Feuvre, Claude Le, et al.. (1993). Prognostic value of thallium-201 myocardial scintigraphy after atrial transoesophageal pacing in patients with suspected coronary artery disease. European Heart Journal. 14(9). 1195–1199. 2 indexed citations
18.
Landais, Paul, et al.. (1993). ["White-coat" effect in 35 consecutive patients with hypertension. Quantification method, role of physician-patient dialogue].. PubMed. 86(4). 427–33. 2 indexed citations
19.
Feuvre, Claude Le, et al.. (1992). Treatment of severe mitral regurgitation caused by ischemic papillary muscle dysfunction: Indications for coronary angioplasty. American Heart Journal. 123(4). 860–865. 25 indexed citations
20.
Vacheron, A. (1990). [Current treatment of myocardial infarct: an "all directional" strategy or a reasoned strategy?].. PubMed. 15(1). 1–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026